Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation / 药物分析学报

ABSTRACT

The aim of this study was to develop a diagnostic strategy for esophageal squamous cell carcinoma(ESCC) that combines plasma metabolomics with machine learning algorithms.Plasma-based untargeted metabolomics analysis was performed with samples derived from 88 ESCC patients and 52 healthy controls.The dataset was split into a training set and a test set.After identification of differential me-tabolites in training set,single-metabolite-based receiver operating characteristic (ROC) curves and multiple-metabolite-based machine learning models were used to distinguish between ESCC patients and healthy controls.Kaplan-Meier survival analysis and Cox proportional hazards regression analysis were performed to investigate the prognostic significance of the plasma metabolites.Finally,twelve differential plasma metabolites (six up-regulated and six down-regulated) were annotated.The pre-dictive performance of the six most prevalent diagnostic metabolites through the diagnostic models in the test set were as followsarachidonic acid (accuracy0.887),sebacic acid (accuracy0.867),indoxyl sulfate (accuracy0.850),phosphatidylcholine (PC) (140/00) (accuracy0.825),deoxycholic acid(accuracy0.773),and trimethylamine N-oxide (accuracy0.653).The prediction accuracies of the ma-chine learning models in the test set were partial least-square (accuracy0.947),random forest (accu-racy0.947),gradient boosting machine (accuracy0.960),and support vector machine (accuracy0.980).Additionally,survival analysis demonstrated that acetoacetic acid was an unfavorable prognostic factor(hazard ratio (HR)1.752),while PC (140/00) (HR0.577) was a favorable prognostic factor for ESCC.This study devised an innovative strategy for ESCC diagnosis by combining plasma metabolomics with machine learning algorithms and revealed its potential to become a novel screening test for ESCC.